September 18, 2013 | Israeli biotech startup CureTech, which develops innovative ways to treat cancer, has raised $3.8 million. The finances were raised in a rights issue to majority shareholder Clal.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments